Ghostwriters and guest-writers

American Journal of Sports Medicine

Volumn 38, Issue 11, 2010, Pages 2183-2185

  Reider, Bruce ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; ETHICS; HUMAN; PUBLISHING; RESEARCH ETHICS; STANDARD; UNITED STATES; WRITING;

ETHICS, RESEARCH; HUMANS; PUBLISHING; UNITED STATES; WRITING;

EID: 78449302878     PISSN: 03635465     EISSN: 15523365     Source Type: Journal    
DOI: 10.1177/0363546510386548     Document Type: Editorial

References (17)

1. Anekwe TD Profits and plagiarism: The case of medical ghostwriting. Bioethics. 2010 ; 24 (6). 267-272.
2. Barnett A. Revealed: how drug firms ĝ€hoodwinkg medical journals. The Observer. Sunday 7 December 2003.
3. Brennan TA Buying editorials [comment]. New Engl J Med. 1994 ; 331 (1). 673-675.
4. Elliott C., Landa AS Whatgs wrong with ghostwriting? Bioethics. 2010 ; 24 (6). 284-286.
5. Ghost writing initiated by commercial companies. WAME Policy Statement, June 20, 2005. Available at http://www.wame.org/resources/policies#ghost. Accessed September 13, 2010.
6. Ghostwriting in Medical Literature. Minority Staff Report, 111th Congress, United States Senate Committee on Finance, June 24, 2010.
7. Gøtzsche PC, Hrobjartsson A., Johansen HK, et al. Ghost authorship in industry-initiated randomised trials. PLOS Med. 2007 ; 4 ( 1 ):e 19. Doi:10.1371/journal.pmed.0040019. (Pubitemid 46191820)
8. Gøtzsche PC, Kassirer JP, Woolley KL, et al. What should be done to tackle ghostwriting in the medical literature? PLOS Med. 2009 ; 6 ( 2 ):e 1000023. Doi:10.1371/journal.pmed.1000023.
9. Graf C., Battisti WP, Bridges D., et al. Good publication practice for communicating company sponsored medical research: the GPP2 guidelines. BMJ. 2009 ; 339 :b 4330.
10. Healy D., Cattell D. Interface between authorship, industry and science in the domain of therapeutics. Br J Psychiatr. 2003 ; 183: 22-27.
11. Ngai S., Gold JL, Gill SS, Rochon PA Haunted manuscripts: Ghost authorship in the medical literature. Accountability in Research. 2005 ; 12: 103-114.
12. Norris R., Bowman A., Fagan JM, et al. International Society for Medical Publication Professionals (ISMPP) position statement: the role of the professional medical writer. Curr Med Res Opin. 2007 ; 23 (8). 1837-1840.
13. Shapiro JS Contested Will: Who Wrote Shakespeare? New York: Simon & Schuster, 2010.
14. Singer N. Report urges more curbs on medical ghostwriting. New York Times. June 24, 2010
15. Sismondo S., Doucet M. Publication ethics and the ghost management of medical publication. Bioethics. 2010 ; 24 (6). 273-283.
16. Steinman MA, Bero LA, Chren M., Londefeld CS Narrative review: The promotion of gabapentin: An analysis of internal industry documents. Ann Intern Med. 2006 ; 145: 284-293.
17. Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Ethical considerations in the conduct and reporting of research: Authorship and contributorship. Available at http://www.icmje.org/ethical-1author.html. Accessed September 13, 2010